February 12 2020
In Allelica we’re very excited about the incredible advances that analyses of large DNA datasets are bringing to medicine.
In addition to the increasingly nuanced view of the polygenic complexity of common disease, these studies confirm that your DNA doesn’t, on its own, determine disease.
It’s usually the case that your risk of disease is modulated by a combination of multiple factors including your lifestyle, diet, general health and age. And, of course, genetics also plays a role.
We also know that modulating these non-genetic factors can lead to improvements in lifetime risk of disease.
January 29 2020
Vast quantities of human DNA have been sequenced for biomedical research and clinicians, researchers and innovators are now beginning to focus on the next phase of the genomic revolution: translating these data into tools that aim to make a difference in the real world.
At the “ESC 2019 together with World Congress of Cardiology”, held in Paris in the first week of September, Allelica presented the newly developed software to compute Polygenic Risk Score (PRS) for Coronary Artery Disease. The clinical value of integrating PRS in traditional risk models was also discussed.
Come to meet us in Basel, Switzerland, at the GenomicsLive Conference. The Europe’s leading conference designed to deliver diagnostics and digital technologies into the clinic. The event will cover diagnostics, digital pathology and clinical aspects of precision medicine. See you at our booth on the 4th and the 5th of December.
January 23 2020
In the late 19th Century, a Moravian monk named Gregor Mendel passed his time by running experiments cross-breeding different types of pea plant.
Amongst his botanical collection of perennials he had legumes with a variety of physical characteristics. He had short and tall pea plants, pea plants with different coloured flowers, and plants with different types of leaf and pea shape.
January 15 2020
A central goal of preventative medicine is to identify the people most at risk of disease early enough that something can be done. Spotting those at higher risk of getting cancer, for example, means that screening programs can be targeted at this group, allowing the disease to be caught early and dealt with whilst it’s relatively cheap and the cancer is small. As we learn more about the drivers of many diseases, from breast cancer to cardiovascular disease, understanding the combination of factors that contribute to the development of disease will provide information that will help people reduce their risk through lifestyle change and therapeutics.